908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference
30 Mai 2023 - 1:00PM
Business Wire
Key oral presentation highlights the company’s
prototype microfluidic chips for multi-omics workflows
908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built
handheld and desktop devices for chemical and biochemical analysis,
is showcasing its ZipChip CE-MS device for rapid characterization
of critical product quality attributes for biologics,
oligonucleotides, RNAs, and AAVs, with an oral presentation,
seminar and 17 posters at the 71st ASMS Conference on Mass
Spectrometry and Allied Topics, June 4-8 in Houston. The majority
of the scientific presentations are results from collaborators and
key opinion leaders such as Weizmann Institute of Science, Dyne
Therapeutics, Regeneron Pharmaceuticals, CPI, University of
Wisconsin-Madison, and University of Connecticut.
Join the Revolution
908 Devices is revolutionizing chemical and biochemical analysis
with its mass spec devices that are simple to operate, provide
answers in minutes and are used at the point of need. The company’s
ZipChip device leverages microchip-based Capillary Electrophoresis
(CE) and nano-electrospray ionization technology to minimize sample
prep burden, perform high-speed and high-resolution separations,
and directly introduce samples into a Thermo Fisher Scientific,
Bruker or Sciex mass spectrometer.
A key highlight of the company’s presence at the ASMS conference
is its breakfast seminar on Protein Characterization of Biologics
using Microchip CE-MS: From mAbs to AAVs, on Monday, June 5 at 7 am
CT. Dr. Jonathan Bones and Dr. Josh Smith from the National
Institute of Bioprocessing Research and Training (NIBRT) in Ireland
share application highlights of using ZipChip for characterizations
on proteins and adeno-associated virus (AAV). Dr. Bones will
highlight his lab’s use of ZipChip for multi-characterization of
proteins in applications including charge variant analysis, peptide
mapping, and released glycan analysis of therapeutic proteins. He
will also discuss ZipChip’s key advantages such as versatility,
high sensitivity, short analysis times and lack of method
development. Dr. Smith will highlight the successful use of ZipChip
for rapid analysis of various serotypes of the AAVs. The detailed
collaboration results are presented in three separate posters at
this ASMS.
In a key oral presentation, Dr. Will Thompson from 908 Devices
will present his collaboration with Professor Marc Foster from Duke
University on Unifying the Multi-Omics World with Microchip
Capillary Electrophoresis: Discovering Secrets in Six Dimensions
from One Drop of Dried Blood. In this work, Dr. Thompson will
describe a workflow using the company’s prototype microfluidic
chips for its ZipChip capillary electrophoresis device coupled to a
mass spec instrument, which allows independent metabolomic,
peptidomic, top-down and bottom-up proteomics from a single sample
containing 20 uL of dried blood.
In addition, 908 Devices will present another two posters on
quantitation of amino acids in cell culture media using its REBEL
desktop CE-MS device, a first-of-its-kind fresh and spent media
analyzer that enables biopharma researchers to accelerate process
development cycles and maximize bioreactor utilization by running
media analysis at-line.
Exhibit and Presentations at ASMS
908 Devices will exhibit its handheld and desktop devices in
booth #603 at ASMS. To see a complete list of posters the company
is presenting with its collaborators and to register for the
breakfast seminar, visit www.908devices.com/asms.
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis
with its simple handheld and desktop devices, addressing
critical-to-life applications. The Company’s devices are used at
the point-of-need to interrogate unknown and invisible materials
and provide quick, actionable answers to directly address some of
the most critical problems in life sciences research,
bioprocessing, pharma/biopharma, forensics and adjacent markets.
The Company is headquartered in the heart of Boston, where it
designs and manufactures innovative products that bring together
the power of mass spectrometry, microfluidic sampling and
separations, software automation, and machine learning.
Forward Looking Statements
This press release includes “forward looking statements” within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements other than statements of historical facts are
forward-looking statements, including, without limitation,
statements regarding the expected uses and capabilities of the
Company’s products. Words such as “may,” “will,” “expect,” “plan,”
“anticipate,” “estimate,” “intend” and similar expressions (as well
as other words or expressions referencing future events, conditions
or circumstances) are intended to identify forward-looking
statements. These forward-looking statements are based on
management’s current expectations and involve known and unknown
risks, uncertainties and assumptions which may cause actual results
to differ materially from any results expressed or implied by any
forward-looking statement, including the risks outlined under “Risk
Factors” and elsewhere in the Company’s filings with the Securities
and Exchange Commission which are available on the SEC's website at
www.sec.gov. Additional information will be made available in the
Company’s annual and quarterly reports and other filings that it
makes from time to time with the SEC. Although the Company believes
that the expectations reflected in its forward-looking statements
are reasonable, it cannot guarantee future results. The Company has
no obligation, and does not undertake any obligation, to update or
revise any forward-looking statement made in this press release to
reflect changes since the date of this press release, except as may
be required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230530005225/en/
Media Barbara Russo brusso@908devices.com
Investors Carrie Mendivil IR@908devices.com
908 Devices (NASDAQ:MASS)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
908 Devices (NASDAQ:MASS)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025